Health Condition 1: D229- Melanocytic nevi, unspecified
Conditions
Interventions
Intervention1: Fractional picosecond 1064 nm laser: One half - fractional picosecond 1064 nm laser will be done with 8mm spot size and fluence starting at 0.4J/cm2 until pin point bleeding is achieved
Sponsors
None listed
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients of both genders and all age groups. 2. Patients willing to participate in the study with their informed consent.
Exclusion criteria
Exclusion criteria: 1.Patients suffering from severe systemic comorbidities and pregnant and lactating women. 2.Patients having active cutaneous infection. 3.Patient having keloidal tendency. 4.Patients having photosensitive disorders. 5.Patients with skin malignancy
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To compare the efficacy and safety of fractional picosecond 1064 nm laser and standard picosecond laser in the treatment of nevus of OtaTimepoint: After 4 months | — |
Secondary
| Measure | Time frame |
|---|---|
| Objective evaluation Hyperpigmentation at baseline will be assessed and dilution will be noted at months 1,2,3 and 4 using Quantificare analysis software and dermoscopic images. Subjective evaluation Photographic documentation with consistent room lightening and proper patient positioning will be done at the baseline and at months 1,2,3 and 4 monthsTimepoint: After 4 months | — |
Countries
India
Contacts
Public ContactDr Chaithra Shenoy
CUTIS Academy of Cutaneous Sciences
Outcome results
None listed